Table 3. M2R Binding Data (pKi or pIC50 Values) of Various Orthosteric (1 and 6), Allosteric (13–15), Dualsteric (7 and 10) MR Ligands, and 64 Determined with [3H]44, [3H]64, or [3H]5.
ligand | [3H]44 pKia | [3H]64 pKia | [3H]5 pKi* or pIC50**b |
---|---|---|---|
1 | 5.78 ± 0.05 | 6.55 ± 0.05* | |
6 | 8.52 ± 0.26 | 8.52 ± 0.14 | 9.04 ± 0.08* |
7 | 7.71 ± 0.14 | 8.71 ± 0.05* | |
10 | 9.61 ± 0.11 | 8.35 ± 0.09 | 9.11 ± 0.05* |
13 | 5.60 ± 0.07 | 6.11 ± 0.09**c | |
14 | 5.90 ± 0.22 | 6.08 ± 0.28 | 6.32 ± 0.18**c |
15 | 5.43 ± 0.02 | <4.5**c | |
64 | 9.44 ± 0.01 | 9.44 ± 0.06* |
Determined by equilibrium competition binding with [3H]44 (2 nM) or [3H]64 (0.3 nM) at CHO-hM2R cell homogenates; mean values ± SEM from at least three independent experiments (performed in triplicate).
Determined by equilibrium competition binding with [3H]5 (0.2 nM) at live CHO-hM2R cells; mean ± SEM from at least three independent experiments (performed in triplicate).
Reported by Pegoli et al.23